{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T09:12:29Z","timestamp":1723021949040},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3-4","license":[{"start":{"date-parts":[[2014,2,26]],"date-time":"2014-02-26T00:00:00Z","timestamp":1393372800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s11046-014-9730-z","type":"journal-article","created":{"date-parts":[[2014,2,25]],"date-time":"2014-02-25T08:21:03Z","timestamp":1393316463000},"page":"157-166","source":"Crossref","is-referenced-by-count":14,"title":["Evaluation of Etest Performed in Mueller\u2013Hinton Agar Supplemented with Glucose for Antifungal Susceptibility Testing of Clinical Isolates of Filamentous Fungi"],"prefix":"10.1007","volume":"177","author":[{"given":"E.","family":"Pinto","sequence":"first","affiliation":[]},{"given":"M.","family":"Lago","sequence":"additional","affiliation":[]},{"given":"L.","family":"Branco","sequence":"additional","affiliation":[]},{"given":"L. A.","family":"Vale-Silva","sequence":"additional","affiliation":[]},{"given":"M. D.","family":"Pinheiro","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2014,2,26]]},"reference":[{"key":"9730_CR1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.eimc.2011.09.004","volume":"30","author":"J Pem\u00e1n","year":"2012","unstructured":"Pem\u00e1n J, Salavert M. General epidemiology of invasive fungal disease. Enferm Infect Microbiol Clin. 2012;30:90\u20138.","journal-title":"Enferm Infect Microbiol Clin"},{"key":"9730_CR2","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1128\/JCM.00940-09","volume":"47","author":"MA Pfaller","year":"2009","unstructured":"Pfaller MA, Diekema DJ, Ghannoum MA, Rex JH, Alexander BD, Andes D, et al. Wild-type MIC distribution and epidemiological cutoff values for Aspergillus fumigatus and three triazoles as determined by the Clinical and Laboratory Standards Institute broth microdilution methods. J Clin Microbiol. 2009;47:3142\u20136.","journal-title":"J Clin Microbiol"},{"key":"9730_CR3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1469-0691.2008.01978.x","volume":"14","author":"M Richardson","year":"2008","unstructured":"Richardson M, Lass-Fl\u00f6rl C. Changing epidemiology of systemic fungal infections. Clin Microbiol Infect. 2008;14:5\u201324.","journal-title":"Clin Microbiol Infect"},{"key":"9730_CR4","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1439-0507.2011.02032.x","volume":"54","author":"MH Miceli","year":"2011","unstructured":"Miceli MH, Lee SA. Emerging moulds: epidemiological trends and antifungal resistance. Mycoses. 2011;54:666\u201378.","journal-title":"Mycoses"},{"key":"9730_CR5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","volume":"46","author":"TJ Walsh","year":"2008","unstructured":"Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2008;46:327\u201360.","journal-title":"Clin Infect Dis"},{"key":"9730_CR6","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2217\/fmb.10.34","volume":"5","author":"C Lass-Fl\u00f6rl","year":"2010","unstructured":"Lass-Fl\u00f6rl C. In vitro susceptibility testing in Aspergillus species: an update. Future Microbiol. 2010;5:789\u201399.","journal-title":"Future Microbiol"},{"key":"9730_CR7","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1093\/jac\/dkq279","volume":"65","author":"A Bueid","year":"2010","unstructured":"Bueid A, Howard SJ, Moore CB, Richardson MD, Harrison E, Bowyer P, et al. Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009. J Antimicrob Chemother. 2010;65:2116\u20138.","journal-title":"J Antimicrob Chemother"},{"key":"9730_CR8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/2047-783X-16-4-153","volume":"6","author":"A Mayr","year":"2011","unstructured":"Mayr A, Lass-Fl\u00f6rl C. Epidemiology and antifungal resistance in invasive aspergillosis according to primary disease: review of the literature. Eur J Med Rev. 2011;6:153\u20137.","journal-title":"Eur J Med Rev"},{"key":"9730_CR9","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1128\/AAC.00335-08","volume":"53","author":"C Lass-Fl\u00f6rl","year":"2009","unstructured":"Lass-Fl\u00f6rl C, Alastruey-Izquierdo A, Cuenca-Estrella M, Perkhofer S, Rodriguez-Tudela JL. In vitro activities of various antifungal drugs against Aspergillus terreus: global assessment using the methodology of the European committee on antimicrobial susceptibility testing. Antimicrob Agents Chemother. 2009;53:794\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"9730_CR10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1469-0691.2011.03714.x","volume":"18","author":"P Escribano","year":"2012","unstructured":"Escribano P, Pel\u00e1ez T, Recio S, Bouza E, Guinea J. Characterization of clinical strains of Aspergillus terreus complex: molecular identification and antifungal susceptibility to azoles and amphotericin B. Clin Microbiol Infect. 2012;18:24\u20136.","journal-title":"Clin Microbiol Infect"},{"key":"9730_CR11","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/jac\/dkn022","volume":"61","author":"A Alastruey-Izquierdo","year":"2008","unstructured":"Alastruey-Izquierdo A, Cuenca-Estrella M, Monz\u00f3n A, Mellado E, Rodriguez-Tudela JL. Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods. J Antimicrob Chemother. 2008;61:805\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"9730_CR12","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1128\/AAC.50.3.917-921.2006","volume":"50","author":"M Cuenca-Estrella","year":"2006","unstructured":"Cuenca-Estrella M, Gomez-Lopez A, Mellado E, Buitrago MJ, Monzon A, Rodriguez-Tudela JL. Head-to-head comparison of the activities of currently available antifungal agents against 3,378 spanish clinical isolates of yeasts and filamentous fungi. Antimicrob Agents Chemother. 2006;50:917\u201321.","journal-title":"Antimicrob Agents Chemother"},{"key":"9730_CR13","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1128\/JCM.00536-10","volume":"48","author":"A Espinel-Ingroff","year":"2010","unstructured":"Espinel-Ingroff A, Diekema DJ, Fothergill A, Johnson E, Pelaez T, Pfaller MA, et al. Wild-type MIC distributions and epidemiological cutoff values for the triazoles and six Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document). J Clin Microbiol. 2010;48:3251\u20137.","journal-title":"J Clin Microbiol"},{"key":"9730_CR14","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1128\/AAC.00156-08","volume":"52","author":"JL Rodriguez-Tudela","year":"2008","unstructured":"Rodriguez-Tudela JL, Alcazar-Fuoli L, Mellado E, Alastruey-Izquierdo A, Monzon A, Cuenca-Estrella M. Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus. Antimicrob Agents Chemother. 2008;52:2468\u201372.","journal-title":"Antimicrob Agents Chemother"},{"key":"9730_CR15","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1128\/JCM.02136-10","volume":"49","author":"M Pfaller","year":"2011","unstructured":"Pfaller M, Boyken L, Hollis R, Kroeger J, Messer S, Tendolkar S, et al. Use of epidemiological cutoff values to examine 9-year trends in susceptibility of Aspergillus species to the triazoles. J Clin Microbiol. 2011;49:586\u201390.","journal-title":"J Clin Microbiol"},{"key":"9730_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1439-0507.2009.01813.x","volume":"53","author":"C Lass-Fl\u00f6rl","year":"2010","unstructured":"Lass-Fl\u00f6rl C, Perkhofer S, Mayr A. In vitro susceptibility testing in fungi: a global perspective on a variety of methods. Mycoses. 2010;53:1\u201311.","journal-title":"Mycoses"},{"key":"9730_CR17","unstructured":"Clinical and Laboratory Standards Institute Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; Approved standard. Second edition 2008 CLSI document M38-A2, Wayne, PA."},{"key":"9730_CR18","doi-asserted-by":"crossref","unstructured":"Subcommittee on Antifungal Susceptibility Testing of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST) Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds. Clin Microbiol Infect. 2008;14: 982\u20134.","DOI":"10.1111\/j.1469-0691.2008.02086.x"},{"key":"9730_CR19","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1586\/eri.10.2","volume":"8","author":"M Cuenca-Estrella","year":"2010","unstructured":"Cuenca-Estrella M, Rodriguez-Tudela JL. The current role of the reference procedures by CLSI and EUCAST in the detection of resistance to antifungal agents in vitro. Expert Rev Anti Infect Ther. 2010;8:267\u201376.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"9730_CR20","volume-title":"Food and Indoor Fungi","author":"RA Samson","year":"2010","unstructured":"Samson RA, Houbraken J, Thrane U, Frisvad JC, Andersen B. Food and Indoor Fungi. The Netherlands: CBS-KNAW fungal biodiversity centre Utrecht; 2010."},{"key":"9730_CR21","volume-title":"Atlas of clinical fungi","year":"2002","unstructured":"De Hoog GS, Guarro J, Gen\u00e9 J, Figueras MJ, editors. Atlas of clinical fungi. 2nd ed. Utrecht\/Reus: Centraalbureau voor Schimmelcultures\/Universitat Rovira i Virgili; 2002.","edition":"2"},{"key":"9730_CR22","first-page":"755","volume":"49","author":"D Coelho","year":"2011","unstructured":"Coelho D, Silva S, Vale-Silva L, Gomes H, Pinto E, Sarmento A, et al. Aspergillus viridinutans: an agent of adult chronic invasive aspergillosis. Med Mycol. 2011;49:755\u20139.","journal-title":"Med Mycol"},{"key":"9730_CR23","doi-asserted-by":"crossref","first-page":"814","DOI":"10.5301\/ejo.5000152","volume":"22","author":"L Figueira","year":"2012","unstructured":"Figueira L, Pinheiro D, Moreira R, Pinto E, Sim\u00f5es J, Camisa E, et al. Beauveria bassiana keratitis in bullous keratopathy: antifungal sensitivity testing and management. Eur J Ophthalmol. 2012;22:814\u20138.","journal-title":"Eur J Ophthalmol"},{"key":"9730_CR24","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.1128\/AAC.00686-11","volume":"55","author":"A Espinel-Ingroff","year":"2011","unstructured":"Espinel-Ingroff A, Cuenca-Estrella M, Fothergill A, Fuller J, Ghannoum M, Johnson E, et al. Wild-type MIC distributions and epidemiological cutoff values for amphotericin B and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document). Antimicrob Agents Chemother. 2011;55:5150\u20134.","journal-title":"Antimicrob Agents Chemother"},{"key":"9730_CR25","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1128\/AAC.01730-10","volume":"55","author":"A Espinel-Ingroff","year":"2011","unstructured":"Espinel-Ingroff A, Fothergill A, Fuller J, Johnson E, Pelaez T, Turnidge J. Wild-type MIC distributions and epidemiological cutoff values for caspofungin and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document). Antimicrob Agents Chemother. 2011;55:2855\u20139.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-014-9730-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11046-014-9730-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-014-9730-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T23:16:50Z","timestamp":1565219810000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11046-014-9730-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,26]]},"references-count":25,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["9730"],"URL":"https:\/\/doi.org\/10.1007\/s11046-014-9730-z","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,26]]}}}